At Mallinckrodt, we’ve been formulating and supplying pharmaceutical products for more than 145 years. We offer a comprehensive generics product portfolio with an emphasis on pain management. Through our unique, five-step Vertically Integrated Process, we control every step of product development – from the farmer’s field to active ingredient processing, through formulation, manufacturing, packaging and distribution.
This process, which is one of the many ways we demonstrate our commitment to being a leader in generic pharmaceuticals, allows us to:
Mallinckrodt Pharmaceuticals is one of the top 12 U.S. generic pharmaceutical companies with more than 77 million prescriptions dispensed annually.1 Our hydrocodone family of products is one of the most dispensed generic pharmaceuticals in the United States.
Look for more progress to come as we add to our line new products, strengths, unit dose and unit of use packaging. Through our service to the retail, health systems, and government markets, we are proud to provide healthcare solutions for both pharmacists and their patients.
1 Source: IMS Health, National Prescription Audit, December, 2012
Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.
© 2017 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.